{"log_id": 8277677138778226011, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 6e-06, "average": 0.998962, "min": 0.986065}, "location": {"width": 923, "top": 191, "height": 43, "left": 163}, "words": "现有资料提示,严重过量能导致外周血管过度扩张并可能引起反射性心动过速。有出现显著"}, {"probability": {"variance": 3.7e-05, "average": 0.997251, "min": 0.978284}, "location": {"width": 441, "top": 246, "height": 30, "left": 115}, "words": "而持久的全身性低血压及致命性休克的报道"}, {"probability": {"variance": 9e-06, "average": 0.998497, "min": 0.982389}, "location": {"width": 920, "top": 296, "height": 41, "left": 163}, "words": "健康志愿者服用氨氯地平10mg后,立即或在2小时内服用活性炭可显著减少氨氯地平的吸"}, {"probability": {"variance": 4e-06, "average": 0.998863, "min": 0.990171}, "location": {"width": 958, "top": 349, "height": 40, "left": 111}, "words": "收。使用本品过量可洗胃,引起明显低血压时,要求积极的心血管支持治疗,包括心肺功能监护"}, {"probability": {"variance": 2.1e-05, "average": 0.997951, "min": 0.976204}, "location": {"width": 961, "top": 400, "height": 43, "left": 111}, "words": "抬高肢体、注意循环液体量和尿量。为恢复血管张力和血压,在无禁忌症时亦可采用血管收缩剂"}, {"probability": {"variance": 1e-06, "average": 0.999334, "min": 0.996587}, "location": {"width": 969, "top": 453, "height": 42, "left": 110}, "words": "静脉注射葡萄糖酸钙对逆转钙抗剂的效应也是有益的。由于本品与血浆蛋白结合率高,所以透"}, {"probability": {"variance": 0, "average": 0.99949, "min": 0.999133}, "location": {"width": 165, "top": 508, "height": 27, "left": 109}, "words": "析治疗是无益的"}, {"probability": {"variance": 0.000114, "average": 0.985592, "min": 0.974935}, "location": {"width": 151, "top": 496, "height": 67, "left": 373}, "words": "股份"}, {"probability": {"variance": 1e-06, "average": 0.999309, "min": 0.997826}, "location": {"width": 129, "top": 558, "height": 29, "left": 166}, "words": "【药理毒理】"}, {"probability": {"variance": 0, "average": 0.999472, "min": 0.999156}, "location": {"width": 97, "top": 611, "height": 26, "left": 158}, "words": "药理作用"}, {"probability": {"variance": 0, "average": 0.961152, "min": 0.961152}, "location": {"width": 82, "top": 561, "height": 86, "left": 405}, "words": "★"}, {"probability": {"variance": 0.00607, "average": 0.976712, "min": 0.648188}, "location": {"width": 919, "top": 660, "height": 43, "left": 157}, "words": "本品为钙离子阻滞剂亦即慢通道阻剂或钙离子拮抗剂),阻滞钙离子跨膜进入心肌和血"}, {"probability": {"variance": 0, "average": 0.999458, "min": 0.998925}, "location": {"width": 143, "top": 713, "height": 28, "left": 106}, "words": "管平滑肌细胞"}, {"probability": {"variance": 1.4e-05, "average": 0.998214, "min": 0.982548}, "location": {"width": 919, "top": 763, "height": 46, "left": 157}, "words": "本品抗高血压作用的机制是直接松弛血管平滑肌。缓解心绞痛的确切机制还未完全肯定,但"}, {"probability": {"variance": 1e-06, "average": 0.999479, "min": 0.995507}, "location": {"width": 966, "top": 815, "height": 44, "left": 107}, "words": "它可以扩张外周小动脉和冠状动脉,减少总外周血管阻力,解除冠状动脉痉挛,降低心脏的后负"}, {"probability": {"variance": 2.6e-05, "average": 0.998635, "min": 0.974431}, "location": {"width": 561, "top": 866, "height": 39, "left": 103}, "words": "荷,减少心脏能量消耗和对氧的需求,从而缓解心绞痛"}, {"probability": {"variance": 1.1e-05, "average": 0.997898, "min": 0.984965}, "location": {"width": 919, "top": 918, "height": 44, "left": 153}, "words": "氨氯地平( NORVASC)血管作用前瞻性随机评估临床试验( PREVENT)研究了其对心血管病发"}, {"probability": {"variance": 5.5e-05, "average": 0.997782, "min": 0.95235}, "location": {"width": 970, "top": 969, "height": 45, "left": 102}, "words": "病率和死亡率、冠状动脉粥样硬化进展及颈动脉粥样硬化的影响。该多中心、随机、双盲、安慰"}, {"probability": {"variance": 1e-06, "average": 0.999448, "min": 0.995568}, "location": {"width": 973, "top": 1021, "height": 46, "left": 100}, "words": "剂对照研究,对825例经血管造影证实的冠心病病人随诊了3年。此人群中包括有心肌梗死病史"}, {"probability": {"variance": 1e-05, "average": 0.998054, "min": 0.980502}, "location": {"width": 968, "top": 1073, "height": 45, "left": 102}, "words": "的(45%),曾做过PTCA的(42%),或有心绞痛病史的(69%)。冠心病的严重程度从单支"}, {"probability": {"variance": 0.002442, "average": 0.986697, "min": 0.660508}, "location": {"width": 969, "top": 1124, "height": 46, "left": 101}, "words": "血管病变(45%)到3支血管病变(21%)。高血压未得到控制的病人(DBP>95mmHg)被排除在"}, {"probability": {"variance": 2e-06, "average": 0.999012, "min": 0.994172}, "location": {"width": 968, "top": 1177, "height": 45, "left": 101}, "words": "本研究之外。主要的心血管事件由不了解内情的终点委员会裁定。虽然未能证实氨氯地平减慢冠"}, {"probability": {"variance": 0.000232, "average": 0.996932, "min": 0.899705}, "location": {"width": 972, "top": 1229, "height": 46, "left": 98}, "words": "状病变速度的效应,但其能阻止颈动脉内膜一中度厚度的增加。氨氯地平治疗的病人中,心血管"}, {"probability": {"variance": 0.00307, "average": 0.98973, "min": 0.619851}, "location": {"width": 967, "top": 1282, "height": 45, "left": 98}, "words": "病死亡,心肌梗死、脑卒中、PTCA,冠状动脉旁路移植术(CABG)、因不稳定性心绞痛住院和充"}, {"probability": {"variance": 0.007024, "average": 0.982909, "min": 0.433455}, "location": {"width": 896, "top": 1335, "height": 43, "left": 98}, "words": "血性心衰(CHF)恶化的综合终点指标显著降低(-31%)。血管重建手术(PTCA和CAB"}, {"probability": {"variance": 0.01229, "average": 0.881476, "min": 0.770618}, "location": {"width": 69, "top": 1325, "height": 62, "left": 1014}, "words": "也明"}, {"probability": {"variance": 0.001831, "average": 0.988308, "min": 0.754035}, "location": {"width": 802, "top": 1387, "height": 43, "left": 99}, "words": "显减少(-42%)。与安慰剂组相比,不稳定性心绞痛住院率亦降低(-33%)"}, {"probability": {"variance": 0, "average": 0.999633, "min": 0.998969}, "location": {"width": 96, "top": 1441, "height": 29, "left": 142}, "words": "毒性研究"}, {"probability": {"variance": 0, "average": 0.999773, "min": 0.999523}, "location": {"width": 95, "top": 1494, "height": 26, "left": 141}, "words": "遗传毒性"}, {"probability": {"variance": 0.05621, "average": 0.86298, "min": 0.452332}, "location": {"width": 296, "top": 1463, "height": 106, "left": 755}, "words": "仅供医个"}, {"probability": {"variance": 0.000878, "average": 0.991521, "min": 0.872199}, "location": {"width": 790, "top": 1543, "height": 44, "left": 143}, "words": "致突变研究显示无论是在基因还是染色体水平均未见与药物相关的致突变作用"}, {"probability": {"variance": 1e-06, "average": 0.99913, "min": 0.997201}, "location": {"width": 96, "top": 1598, "height": 26, "left": 143}, "words": "生殖毒性"}, {"probability": {"variance": 0.00258, "average": 0.926648, "min": 0.875851}, "location": {"width": 161, "top": 1550, "height": 70, "left": 945}, "words": "专用"}, {"probability": {"variance": 0.000224, "average": 0.995198, "min": 0.906555}, "location": {"width": 920, "top": 1646, "height": 49, "left": 142}, "words": "大鼠(雄性大鼠交配前64天起,雌性大鼠交配前14天起)给予剂量达10mg/kg/天氨氯地"}], "language": 3}